Dow Up 0.12% Nasdaq Up 1.35%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.39 0.12(5.29%)
Prev Close:2.27
Open:N/A
Bid:2.37 x 2500
Ask:2.38 x 2500
1y Target Est:5.25
Beta:1.64
Next Earnings Date:29-Oct-14CTIC Earnings announcement
Day's Range:2.27 - 2.40
52wk Range:1.60 - 4.25
Volume:N/A
Avg Vol (3m):1,120,640
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICUp 5.29%N/A
BMYN/A
RHHBYN/A
SNYN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback